Unlike TP53, a bona fide tumor suppressor gene, which is mutated in 50% of human tumors [16, 17, 18, 19], a great body of work has revealed that TP73 is rarely mutated in cancer [20, 21, 22, 23, 24, 25]. This evidence concerns the gene TP73 and cancer.